A pair of recent studies show a potential link between semaglutide and tirzepatide, the active ingredients in many weight loss drugs, and a condition that leads to a stroke of the eye
The gut microbiome, the complex community of bacteria residing in the large intestine, plays a central role in digestive health
These increase testosterone levels, which can also improve erectile function and libido
This method is often used to treat health problems with the lungs
1.0%) and lipid-lowering medications (2.8% vs
Home Medical news & Guidelines Anesthesiology Cardiology and CTVS Critical Care Dentistry Dermatology Diabetes and Endocrinology ENT Gastroenterology Medicine Nephrology Neurology Obstretics-Gynaecology Oncology Ophthalmology Orthopaedics Pediatrics-Neonatology Psychiatry Pulmonology Radiology Surgery Urology Laboratory Medicine Diet Nursing Paramedical Physiotherapy Health news Fact Check Bone Health Fact Check Brain Health Fact Check Cancer Related Fact Check Child Care Fact Check Dental and oral health fact check Diabetes and metabolic health fact check Diet and Nutrition Fact Check Eye and ENT Care Fact Check Fitness fact check Gut health fact check Heart health fact check Kidney health fact check Medical education fact check Men's health fact check Respiratory fact check Skin and hair care fact check Vaccine and Immunization fact check Women's health fact check AYUSH State News Andaman and Nicobar Islands Andhra Pradesh Arunachal Pradesh Assam Bihar Chandigarh Chattisgarh Dadra and Nagar Haveli Daman and Diu Delhi Goa Gujarat Haryana Himachal Pradesh Jammu & Kashmir Jharkhand Karnataka Kerala Ladakh Lakshadweep Madhya Pradesh Maharashtra Manipur Meghalaya Mizoram Nagaland Odisha Puducherry Punjab Rajasthan Sikkim Tamil Nadu Telangana Tripura Uttar Pradesh Uttrakhand West Bengal Medical Education Industry Study Finds GLP-1 RAs May Lower Liver and Heart Complications in MASLD Patients with Diabetes USA: A recent study published in Diabetes, Obesity and Metabolism has reported that the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is linked to a lower risk of liver disease progression, major acute cardiovascular events (MACE), and all-cause mortality in individuals with diabetes and hepatic steatosis
